PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 103 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $263,000 | -12.3% | 92,237 | -11.3% | 0.00% | 0.0% |
| Q1 2022 | $300,000 | -5.4% | 104,027 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $317,000 | +23.8% | 104,010 | +184.7% | 0.00% | 0.0% |
| Q3 2021 | $256,000 | -22.0% | 36,537 | +2.4% | 0.00% | 0.0% |
| Q2 2021 | $328,000 | +16.7% | 35,666 | +23.5% | 0.00% | 0.0% |
| Q1 2021 | $281,000 | +8.5% | 28,874 | +14.3% | 0.00% | 0.0% |
| Q4 2020 | $259,000 | +23.9% | 25,259 | +21.9% | 0.00% | – |
| Q3 2020 | $209,000 | +6.1% | 20,721 | +9.7% | 0.00% | – |
| Q2 2020 | $197,000 | +48.1% | 18,881 | +19.7% | 0.00% | – |
| Q1 2020 | $133,000 | -3.6% | 15,770 | 0.0% | 0.00% | – |
| Q4 2019 | $138,000 | -0.7% | 15,770 | +22.2% | 0.00% | – |
| Q3 2019 | $139,000 | -15.2% | 12,908 | 0.0% | 0.00% | – |
| Q2 2019 | $164,000 | -98.1% | 12,908 | -94.3% | 0.00% | -100.0% |
| Q1 2019 | $8,737,000 | -41.8% | 225,231 | -69.5% | 0.02% | -45.9% |
| Q4 2018 | $15,014,000 | -21.0% | 737,783 | +77.9% | 0.04% | -5.1% |
| Q3 2018 | $19,012,000 | +38.8% | 414,661 | +79.1% | 0.04% | +34.5% |
| Q2 2018 | $13,693,000 | -45.3% | 231,495 | -37.1% | 0.03% | -45.3% |
| Q1 2018 | $25,027,000 | +0.1% | 367,781 | +45.4% | 0.05% | +1.9% |
| Q4 2017 | $25,009,000 | -30.5% | 253,007 | -15.8% | 0.05% | -32.5% |
| Q3 2017 | $35,976,000 | +2974.9% | 300,424 | +2143.3% | 0.08% | +2466.7% |
| Q2 2017 | $1,170,000 | +195.5% | 13,392 | +25.9% | 0.00% | +200.0% |
| Q1 2017 | $396,000 | +21.5% | 10,633 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $326,000 | -54.3% | 10,633 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $713,000 | +124.9% | 10,633 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $317,000 | -1.9% | 10,633 | -3.2% | 0.00% | 0.0% |
| Q1 2016 | $323,000 | -62.8% | 10,981 | -0.9% | 0.00% | -50.0% |
| Q4 2015 | $869,000 | +0.2% | 11,078 | -3.7% | 0.00% | 0.0% |
| Q3 2015 | $867,000 | -36.0% | 11,506 | -0.8% | 0.00% | -33.3% |
| Q2 2015 | $1,354,000 | -91.8% | 11,595 | -83.4% | 0.00% | -91.9% |
| Q1 2015 | $16,540,000 | +40.7% | 70,051 | +12.8% | 0.04% | +42.3% |
| Q4 2014 | $11,754,000 | +0.5% | 62,100 | +26.7% | 0.03% | -3.7% |
| Q3 2014 | $11,695,000 | +1119.5% | 49,019 | +237.3% | 0.03% | +1250.0% |
| Q2 2014 | $959,000 | -39.0% | 14,532 | -3.8% | 0.00% | -50.0% |
| Q1 2014 | $1,573,000 | +0.6% | 15,108 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,564,000 | +114.2% | 15,108 | +11.0% | 0.00% | +100.0% |
| Q3 2013 | $730,000 | +20.9% | 13,608 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $604,000 | – | 13,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |